MDS Virtual Congress 2021 Archives - Page 17 of 132

Bilateral focused ultrasound thalamotomy for essential tremor (BEST-FUS trial): safety and efficacy proof of principle

C. Iorio-Morin, K. Yamamoto, C. Sarica, A. Zemmar, M. Levesque, S. Brisebois, J. Germann, A. Loh, A. Boutet, G. Elias, P. Azevedo, E. Adam, U. Patel, M. Lenis, S. Kalia, M. Hodaie, A. Fasano, A. Lozano (Sherbrooke, Canada)
BILATERAL SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION IN A PATIENT WITH PARKINSON DISEASE AND INTOLERANCE TO STANDARD ANTIPARKINSONIAN DRUGS – A CASE REPORT

M. Tsalta-Mladenov, V. Dimitrova, M. Moynov, S. Andonova, Y. Enchev (Varna, Bulgaria)
Biofluid Biomarkers in Prodromal Parkinson’s Disease

B. Mollenhauer, L. Chahine, M. Dakna, M. Bartl, A. Siderowf, SJ. Hutten, K. Merchant, K. Marek, D. Galasko (Kassel, Germany)
Biomarker candidates – Peptides identified to be differentially abundant in cerebrospinal fluid of patients with Parkinson´s disease

L. Schilde, B. Serschnitzki, F. Maass, M. Bähr, P. Lingor, C. May, K. Marcus (Bochum, Germany)
Blepharospasm – a network disorder

MC. Posirca, R. Ivan, I. Caloianu, M. Mitrica, CA. Sirbu (Bucharest, Romania)
Blindness analyses in STEADY-PD3: a phase III placebo-controlled double-blind randomized trial of Isradipine as a disease modifying agent in early Parkinson Disease

T. Mestre, S. Eberly, C. Grimes, D. Oakes, T. Simuni (Ottawa, Canada)
Blood-based circulating microRNAs for discriminating between Parkinson’s disease subtypes

MT. Periñán, P. Gómez-Garre, S. Jesús, D. Buiza-Rueda, MV. Jimenez-Jaraba, D. Macías-García, AD. Adarmes-Gómez, P. Mir (Seville, Spain)
Body mass index and incidence of Parkinson’s disease in French women from the E3N cohort study

B. Portugal, F. Artaud, C. Domenighetti, E. Roze, I. Dagaey, M. Canonico, A. Elbaz (Villejuif, France)
Both online and in-person JOBGRIP group training for people with Parkinson’s with paid employment is acceptable and perceived to be valuable

I. Sturkenboom, J. Vanomme-Vanlaarhoven, M. Noordegraaf, B. Bloem (Nijmegen, Netherlands)
Botulinum injections for idiopathic cervical dystonia: a longitudinal study

G. Yahalom, T. Fay-Karmon, V. Livneh, S. Israeli-Korn, L. Ephraty, S. Hassin-Baer (Jerusalem, Israel)